Inventor · disambiguated record
Lishan Su
Also filed as: SU LISHAN
8 granted patents·3 pending applications·13 citations·filing 1994–2020
79Inventor score
Files withUNIV NORTH CAROLINA CHAPEL HILL6INST BIOPHYSICS CAS1ONCOIMMUNE INC1SU LISHAN1SYSTEMIX INC1
Top patents by PatentIndex Score
11 records- 0181US11136399B2Type I interferon receptor antibody and use thereofINST BIOPHYSICS CAS·Filed 2016·Granted Oct 5, 2021·5 cites·21 claims
- 0266US11028175B2Depletion of plasmacytoid dendritic cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Granted Jun 8, 2021·0 cites·16 claims
- 0361US9914780B2Depletion of plasmacytoid dendritic cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Granted Mar 13, 2018·0 cites·14 claims
- 0459US9670283B2Depletion of plasmacytoid dendritic cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Jun 6, 2017·0 cites·11 claims
- 0557US12479890B2Chimeric antigen receptor constructs and their use in CAR-T cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Granted Nov 25, 2025·0 cites·17 claims
- 0657US10214587B2Depletion of plasmacytoid dendritic cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Granted Feb 26, 2019·0 cites·17 claims
- 0754US9173383B2Recombinant non-human mammalian model for hepatitis infection and immunopathogenesisSU LISHAN·Filed 2009·Granted Nov 3, 2015·0 cites·9 claims
- 0852US2016106076A1Recombinant non-human mammalian model for hepatitis infection and immunopathogenesisUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 0950US2021046154A1Methods of use of soluble cd24 for treating acquired immune deficiency syndrome (hiv/aids)ONCOIMMUNE INC·Filed 2019·Application pending·0 cites
- 1045US5612018ADrug screening and treatment for HIV thymocyte depletionSYSTEMIX INC·Filed 1994·Granted Mar 18, 1997·8 cites·7 claims
- 1140US2019284286A1Modulation of Type I Interferons to Reactivate HIV-1 Reservoir and Enhance HIV-1 TreatmentUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →